374sek
6,3 %
Date:2024-06-19Time:17:29:30Latest report:Q1-2024List:Small CapTicker:QLINEA
Market Cap:438 msekEnterprise Value:425 msekNet Sales:5,89 msekEarnings:-220,9 msekEmployees:0ISIN:SE0011527845

Ratios

10-year key figure history for Q-Linea turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Q-Linea with index and moving average MA50 and MA200.

Stockprice:3,74
MA50:2,52
MA200:2,79
Price/MA200:34,0 %
RSI (14):67,3
Price/MA50:48,6 %

Description

Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.

Medical Equipment